Combination Therapy Versus Monotherapy and the Risk of Diabetic Ketoacidosis Among Patients on SGLT2 Inhibitors and GLP-1 Receptor Agonists
Recommended Citation
Cecil A, Essien E, Umahi AN, Williams M, Alpizar-Rivas R. Combination Therapy Versus Monotherapy and the Risk of Diabetic Ketoacidosis Among Patients on SGLT2 Inhibitors and GLP-1 Receptor Agonists. Oral presentation at: National American College of Physicians (ACP) Conference; April 16-18; San Francisco, CA.
Presentation Notes
Oral presentation at: National American College of Physicians (ACP) Conference; April 16-18; San Francisco, CA.
Award Information
Podium winner at National American College of Physicians (ACP) Abstract Competition; April 16-18; San Francisco, CA.
Type
Oral/Podium Presentation